Patent ID: 8563580

Claim:
A method of treating a Flavivirus infection in a subject, comprising administering to the subject a therapeutically effective amount of a compound of the following formula: or a pharmaceutically acceptable salt or prodrug thereof, wherein: R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are each independently selected from hydrogen, hydroxyl, substituted or unsubstituted C 1-4 alkyl, substituted or unsubstituted C 1-4 heteroalkyl, substituted or unsubstituted C 2-4 alkenyl, substituted or unsubstituted C 2-4 heteroalkenyl, substituted or unsubstituted C 2-4 alkynyl, substituted or unsubstituted C 2-4 heteroalkynyl, or halogen; A is selected from the group consisting of: B is selected from hydrogen, substituted or unsubstituted C 1-12 alkyl, substituted or unsubstituted C 1-12 heteroalkyl, substituted or unsubstituted C 2-12 alkenyl, substituted or unsubstituted C 2-12 heteroalkenyl, substituted or unsubstituted C 2-12 alkynyl, substituted or unsubstituted C 2-12 heteroalkynyl, substituted or unsubstituted aryl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted arylalkyl, substituted or unsubstituted heteroarylalkyl, substituted or unsubstituted cycloalkylalkyl, and substituted or unsubstituted heterocycloalkylalkyl; and R 7 is hydrogen or an attachment for a cyclic B group, with the proviso that R 1 is not OH if A is and B is